BRTXVSHALO• 12 Months (Normalized)
BRTX vs HALO (BioRestorative Therapies Inc. Common Stock (NV) vs Halozyme Therapeutics Inc.)
Showing Closing Date Range from Oct 6, 2025 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BRTX Performance $2.27
+48.37%
BioRestorative Therapies Inc. Common Stock (NV)
Normalized Baseline0.00%
HALO Performance $109.72
+63.83%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
-15.46 pts
HALO outperforming by 15.46 percentage points
BRTXHALO
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BRTX HALO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BRTX Price | BRTX Gain (%) | HALO Price | HALO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $2.27 | +48.37% | $109.72 | +63.83% | -15.46% |
| Oct 05, 2026 | $2.24 | +46.41% | $108.31 | +61.73% | -15.32% |
| Oct 02, 2026 | $2.14 | +39.87% | $109.86 | +64.04% | -24.17% |
| Oct 01, 2026 | $2.27 | +48.37% | $106.94 | +59.68% | -11.31% |
| Sep 30, 2026 | $2.33 | +52.29% | $110.40 | +64.85% | -12.56% |
| Sep 29, 2026 | $2.33 | +52.29% | $111.56 | +66.58% | -14.29% |
| Sep 28, 2026 | $2.31 | +50.98% | $112.89 | +68.57% | -17.59% |
| Sep 25, 2026 | $2.55 | +66.67% | $113.90 | +70.08% | -3.41% |
| Sep 24, 2026 | $2.51 | +64.05% | $- | - | |
| Sep 23, 2026 | $2.60 | +69.93% | $112.44 | +67.90% | +2.03% |
| Sep 22, 2026 | $2.55 | +66.67% | $115.13 | +71.91% | -5.24% |
| Sep 21, 2026 | $2.71 | +77.12% | $111.45 | +66.42% | +10.70% |
| Sep 18, 2026 | $2.69 | +75.82% | $112.45 | +67.91% | +7.91% |
| Sep 17, 2026 | $2.66 | +73.53% | $109.68 | +63.77% | +9.76% |
| Sep 16, 2026 | $2.55 | +66.67% | $108.44 | +61.92% | +4.75% |
Page 1 of 17